Newou can listen to Fox News articles!
First Fox: Planned Parents are suing the Trump administration on the provisions of large and beautiful bills of reimbursement abortion providers, so Prolife’s health and human services secretary Robert F. Kennedy Jr. to reconsider the broad approval of the FDA’s disruption drug.
In a letter obtained by Fox News Digital, six abortion healthcare institutions representing around 30,000 medical professionals urge Kennedy and FDA commissioner Martin Makary to revive the abortion pirmifepristone safety guard, which was removed since its first approval in 2000.
Medication abortions account for 63% of all abortions in the United States, according to the Guttmacher Institute. The most common form of medication abortion is taking mifepristone, a tablet that blocks the flow of progesterone to the uterus, essentially starving the nutrient fetus. A second pill called misoprostol is taken to expel dead fetuses.
Under the Biden administration, the FDA has significantly expanded approval for Mifepristone, allowing drugs to be obtained through telemedicine without mailing without in-person doctor appointments.
Biden-appointed judge will halt Trump HHS overhaul after Democratic-led lawsuit
Left: HHS Secretary Robert F. Kennedy Jr. Right: Abortion Pills, known as Mifepristone. This is the most common abortion method today. (Roy Rochlin/Getty Images and Erin Hooley/Chicago Tribune/Tribune News Service via Getty Images)
In the letter, groups including the American Odgin Society of Life Systems, the Hippocrates Medicine Alliance, and the American School of Family Medicine warn that the latest data on Mifepristone “strongly suggests” that hundreds of thousands of women have been hurt by using drugs.
Planned Parenthood said on its website that chemical abortion is “safeer than many other drugs, such as penicillin, Tylenol, and Viagra.” However, the letter calls mifepristone “a high-risk abortion inducer known to cause serious adverse effects and medical emergencies, such as bleeding, sepsis, and incomplete abortions requiring surgical intervention.”
The letter cites two reports released this May. One is the American Foundation for Restoration and the other is the Center for Ethics and Public Policy.
The study argued that based on an analysis of health insurance records covering 330 million US patients of 860,000 women receiving mifepristone prescriptions, 10.93% of those women experienced another serious adverse event within 45 days of using sepsis, infection, bleeding, surgical intervention, or medication.
HHS will revive hundreds of staff following the latest rehiring moves’ armed cuts
On June 17, 2022, women’s reproductive clinics offering legal medication abortion services in Santa Teresa, New Mexico, two drugs used for medication abortions, Mifeprex and Misoprostol are found.
Based on this, the letter shows that real-world data on the use of mifepristone “individual patients experience very realistic medical emergencies at an astonishing rate.
“The data strongly suggests that Mifepristone poses a risk of causing much greater harm than previously mentioned. In fact, the risk of serious complications may be 22 times higher than previously disclosed,” the letter states.
In light of this, Aaplog and other groups sign the letter, urging the FDA to conduct a unique assessment of actual data to determine the overall safety of mifepristone in both adult and adolescent populations.
The group will also urge Kennedy and McCurry to recover reports of all adverse events related to mifepristone use and to revive pre-2016 risk assessment and mitigation strategies for drug use.
Wisconsin Supreme Court decides on abortion cases that encouraged the most expensive judicial election in US history
On March 16, 2022, there is a box of drug mifepristone on the shelves of the West Alabama Women’s Center in Tuscaloosa, Alabama.
The letter also stated that ultrasound is necessary to confirm the age of pregnancy in the fetus, and that the group “is important for accurately dating pregnancy and determining the risk of complications.”
“The fundamental doctrine of medical ethics is informed consent, which requires an accurate review of the risks and benefits of proposed interventions specific to patients sitting in front of us based on actual data rather than ideologically driven rhetoric,” the letter states. “No matter how politically accused women of the debate surrounding this drug, they deserve to know the true risks of serious adverse events and medical emergencies after using mifepristone.”
“Americans must be able to trust that no matter what, the FDA relies on the most robust safety standards before and after drug approval and that they can truly have informed consent by knowing what the risks of taking FDA-approved medications are,” the letter states.
The FDA’s broad recognition of mifepristone has been the subject of intense legal debate in recent years, including in the Supreme Court. In 2024, the Supreme Court dismissed a lawsuit filed by the Hippocrates Medicine Alliance, challenging the approval of FDA abortion drugs on the ground that the group was not standing.
Senator Oaks bans federal funding for planning parents at Trump Megaville
WASHINGTON, DC-March 26: In the case of the U.S. Food and Drug Administration and the Hippocrates Medicine Alliance in Washington, DC on March 26, 2024, demonstrators gather before the Supreme Court when the court hears oral debate. The case challenges more than 20 years of legal approval by the FDA of Mifepristone, a commonly used abortion drug. (Photo: Anna Rose Rayden/Getty Images)
Dr. Jack Restneck Jr., then president of the American Medical Association at the time, argued that limiting mifepristone would “have devastating health effects on people living in states where abortion is still legal.”
Resneck Jr. argued that “hundreds of peer-reviewed clinical studies and decades of evidence-based research disproves the plaintiff’s claims in this case and demonstrates the safety of mifepristone.”
According to CBS, after the ethics and public policy report was released, Dr. Cerry Linegounder, CBS News Medical Contributor to KFF Health News and editor of public health, challenged the findings and accused them of the lack of disclosure of data sources.
Gounder also said the study lacked a comparison group to examine how pregnant women compare their experiences with pregnant women who are not taking mifepristone.
A spokesman for Danco, the manufacturer of Mifepristone, told the outlet that the company “stands with confidence behind the established safety and effectiveness record of its products.”
GOP Rep speaks after being forced to evacuate offices over threats from abortion activists
Group of anti-abortion protesters crashes a breeding rally for women’s marching behavior at Mariachi Plaza in Los Angeles, California on October 8, 2022 (David McNee/AFP via Getty Images)
In a statement emailed to Fox News Digital, Dr. Christina Francis, OB-Gyn and CEO of Aaplog, said FDA’s Mifepristone deregulation would be vulnerable to life-threatening complications for pregnant women pregnant with non-pregnant standards of care, and would like to force abusers and unwanted aborites.
Click here to get the Fox News app
“Our doctors have seen the devastating effects this recklessness has had on patients, which makes it clear that the FDA needs to replicate women and girls by revisiting drug safety and reviving basic safeguards that should never have been lifted,” she said.
Other groups that signed the letter are the Christian Medical and Dental Association, the American School of Pediatric Medicine, and the Coptic Medical Association of North America.
Peter Pinedo is a political writer for Fox News Digital.
Source link
